2-[(2,2,2-trifluoroethyl)amino]acetic acid hydrochloride, 98%, 250mg

N-ethyl-2,4-dimethylbenzamide, 95%, 250mg

EDTA dipotassium salt dihydrate, min. 99%, for synthesis, 1 kg, plastic packaging.

GC capillary column ROTI®Cap-1701, 30 m, 0.32 mm, 0.35 µm, 1 Piece(s)

5,5-Dimethyl-2-thioxoimidazolidin-4-one, 97%, 1g

1-Decyl-1H-imidazole, 95.0%, 5g

Benzyltrimethylammonium tribromide, 95.0%, 100g

2-(3-((3-Fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

2-Bromo-1-(ethoxymethyl)-4-nitro-1H-imidazole, 97%, 25g

6-Methyl-5-oxo-4,5-dihydropyrazine-2-carboxylic acid, 95.0%, 250mg

2-Propoxy-5-(trifluoromethyl)aniline, 98%, 250mg

3,5-Di-tert-butyl-4-hydroxybenzyl Ether, 25g

alpha,alpha,alpha',alpha',4,5-Hexabromo-o-xylene>98.0%(GC)5g